Pub Date : 2026-01-27DOI: 10.1016/j.colsurfb.2026.115480
Suraj Kumar , Saurabh Srivastava , Ching Siang Tan , Mohammed Abohashrh , Rishabha Malviya
Biological proteins play a crucial role at the intersection of oral health and neuroscience, offering promising opportunities for improved diagnosis, prevention, and treatment. This review highlights the molecular, inflammatory, and biochemical pathways linking oral diseases, particularly periodontal disease and microbial dysbiosis, with neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. Key inflammatory, neuroprotective, and tissue-repair proteins play a crucial role in maintaining both oral integrity and neural function. Advances in proteomics and molecular imaging have clarified how protein misfolding, aggregation, and immune responses drive neuroinflammation and cognitive decline. Emerging therapies include protein-based biomaterials, such as hydrogels, nanocarriers, and protein–polymer hybrids, for delivering neuroprotective and regenerative agents through oral and nasal routes. Early diagnosis is being transformed by salivary proteomics and transcriptomics, enabling non-invasive detection of neurodegenerative biomarkers. Host-defense peptides and antimicrobial proteins also show promise in controlling oral infections that may exacerbate brain inflammation. Integrating oral biology, biomaterials science, and neuroscience is accelerating clinical translation through the development of innovative scaffolds and smart delivery systems. Despite challenges in biomarker validation and clinical application, advances in artificial intelligence, bioinformatics, and protein engineering are driving the future of personalized regenerative and preventive medicine. Overall, biological proteins provide a critical molecular link between oral and neural health, paving the way for novel non-invasive diagnostic and therapeutic strategies.
{"title":"Correlation between oral disease and neurodegenerative disorders: Role of biological proteins for the modulation of oral-brain axis and gut-brain axis","authors":"Suraj Kumar , Saurabh Srivastava , Ching Siang Tan , Mohammed Abohashrh , Rishabha Malviya","doi":"10.1016/j.colsurfb.2026.115480","DOIUrl":"10.1016/j.colsurfb.2026.115480","url":null,"abstract":"<div><div>Biological proteins play a crucial role at the intersection of oral health and neuroscience, offering promising opportunities for improved diagnosis, prevention, and treatment. This review highlights the molecular, inflammatory, and biochemical pathways linking oral diseases, particularly periodontal disease and microbial dysbiosis, with neurodegenerative disorders such as Alzheimer’s and Parkinson’s disease. Key inflammatory, neuroprotective, and tissue-repair proteins play a crucial role in maintaining both oral integrity and neural function. Advances in proteomics and molecular imaging have clarified how protein misfolding, aggregation, and immune responses drive neuroinflammation and cognitive decline. Emerging therapies include protein-based biomaterials, such as hydrogels, nanocarriers, and protein–polymer hybrids, for delivering neuroprotective and regenerative agents through oral and nasal routes. Early diagnosis is being transformed by salivary proteomics and transcriptomics, enabling non-invasive detection of neurodegenerative biomarkers. Host-defense peptides and antimicrobial proteins also show promise in controlling oral infections that may exacerbate brain inflammation. Integrating oral biology, biomaterials science, and neuroscience is accelerating clinical translation through the development of innovative scaffolds and smart delivery systems. Despite challenges in biomarker validation and clinical application, advances in artificial intelligence, bioinformatics, and protein engineering are driving the future of personalized regenerative and preventive medicine. Overall, biological proteins provide a critical molecular link between oral and neural health, paving the way for novel non-invasive diagnostic and therapeutic strategies.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"262 ","pages":"Article 115480"},"PeriodicalIF":5.6,"publicationDate":"2026-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146076897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-26DOI: 10.1016/j.colsurfb.2026.115474
Yang Liu , Yuan Liu , Chang Xu , Fangming Jiang , Xiaorong Yang
Tumor suppressor p53 formed the droplets with the solidification tendency. Mutations in p53 could accelerate the aggregation of droplets, resulting in p53 to lose the function and/or to gain the oncogenic activity. In this study, the effects of CP-31398 on the phase behaviors of p53 mutants were explored. The results revealed that CP-31398 could inhibit the pathological aggregation of R175H p53, restored the interaction between R175H p53 and specific DNA, and promoted the formation of functional droplets. For R248W p53, CP-31398 could regulate the phase behavior but not restore the formation of functional condensates. Molecular dynamics simulations showed that CP-31398 enhanced the structural stability of R175H p53 by stabilizing the zinc-binding domain and 251–258 segment. These findings provided new insights into the molecular basis that CP-31398 restored the liquid-liquid phase separation of p53 mutant, and could offer the novel therapeutic strategy for cancers with p53 mutant.
{"title":"CP-31398 restored the functional condensates of R175H p53 by stabilizing the zinc-binding domain and 251–258 segment","authors":"Yang Liu , Yuan Liu , Chang Xu , Fangming Jiang , Xiaorong Yang","doi":"10.1016/j.colsurfb.2026.115474","DOIUrl":"10.1016/j.colsurfb.2026.115474","url":null,"abstract":"<div><div>Tumor suppressor p53 formed the droplets with the solidification tendency. Mutations in p53 could accelerate the aggregation of droplets, resulting in p53 to lose the function and/or to gain the oncogenic activity. In this study, the effects of CP-31398 on the phase behaviors of p53 mutants were explored. The results revealed that CP-31398 could inhibit the pathological aggregation of R175H p53, restored the interaction between R175H p53 and specific DNA, and promoted the formation of functional droplets. For R248W p53, CP-31398 could regulate the phase behavior but not restore the formation of functional condensates. Molecular dynamics simulations showed that CP-31398 enhanced the structural stability of R175H p53 by stabilizing the zinc-binding domain and 251–258 segment. These findings provided new insights into the molecular basis that CP-31398 restored the liquid-liquid phase separation of p53 mutant, and could offer the novel therapeutic strategy for cancers with p53 mutant.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"262 ","pages":"Article 115474"},"PeriodicalIF":5.6,"publicationDate":"2026-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146048913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Anisotropic gold nanoparticles with surface plasmon resonance (SPR) can generate heat upon exposure to laser light, which can then be utilised for photothermal therapy (PTT) in cancer treatment. In this study, we report the use of doxorubicin (DOX)-loaded immunomodulatory polysaccharide (PST001) coated anisotropic gold nanostars (AuNS@PST) as a theranostic carrier for photothermal-chemotherapy. AuNS@PST were prepared by green synthesis followed by doxorubicin encapsulation. The synthesized particles were characterized using UV–vis spectroscopy, DLS, FTIR and TEM. The heat dissipation of these nanoparticles was monitored in aqueous phantoms using 635 nm laser sources, which indicated the thermal rise from ambient temperature. The in vitro cytotoxicity analysis of AuNS@PST was done using the MTT assay in A549 cells. Significantly lower IC50 value was observed for cells treated with DOX-loaded PST AuNSs when compared to DOX-alone treated cells. Similarly, DOX-loaded AuNS@PST had efficient photothermal-induced apoptosis exerted by the laser-irradiated nanoparticles. Changes in protein degradation and DNA fragmentation at the subcellular levels were observed in the Raman spectrum. Although supplementary perspectives are required in the proper investigation of laser-mediated cell death in cancer tissues, the current study discloses the emerging methodology to track apoptotic events in cancer tissues using the Raman scattering platform, even at the sub-cellular level.
{"title":"Exploration of sub-cellular responses for the evaluation of the laser mediated tumor ablation via Raman spectroscopic platform using green synthesized gold nanostars","authors":"BS Unnikrishnan , GU Preethi , PT Sujai , Kaustabh Kumar Maiti , TT Sreelekha","doi":"10.1016/j.colsurfb.2026.115472","DOIUrl":"10.1016/j.colsurfb.2026.115472","url":null,"abstract":"<div><div>Anisotropic gold nanoparticles with surface plasmon resonance (SPR) can generate heat upon exposure to laser light, which can then be utilised for photothermal therapy (PTT) in cancer treatment. In this study, we report the use of doxorubicin (DOX)-loaded immunomodulatory polysaccharide (PST001) coated anisotropic gold nanostars (AuNS@PST) as a theranostic carrier for photothermal-chemotherapy. AuNS@PST were prepared by green synthesis followed by doxorubicin encapsulation. The synthesized particles were characterized using UV–vis spectroscopy, DLS, FTIR and TEM. The heat dissipation of these nanoparticles was monitored in aqueous phantoms using 635 nm laser sources, which indicated the thermal rise from ambient temperature. The <em>in vitro</em> cytotoxicity analysis of AuNS@PST was done using the MTT assay in A549 cells. Significantly lower IC<sub>50</sub> value was observed for cells treated with DOX-loaded PST AuNSs when compared to DOX-alone treated cells. Similarly, DOX-loaded AuNS@PST had efficient photothermal-induced apoptosis exerted by the laser-irradiated nanoparticles. Changes in protein degradation and DNA fragmentation at the subcellular levels were observed in the Raman spectrum. Although supplementary perspectives are required in the proper investigation of laser-mediated cell death in cancer tissues, the current study discloses the emerging methodology to track apoptotic events in cancer tissues using the Raman scattering platform, even at the sub-cellular level.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"262 ","pages":"Article 115472"},"PeriodicalIF":5.6,"publicationDate":"2026-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146049234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-23DOI: 10.1016/j.colsurfb.2026.115464
Fengmei Yang , Yutong Chen , Yujiao Yan , Ruixin Zhao , Liran Deng , Die Tian , Meng Xie
Pathological events in Alzheimer’s disease (AD) typically involve β-amyloid (Aβ) plaque deposition, metal ion dysregulation, oxidative stress elevation, and chronic neuroinflammation, making single-target therapies unsatisfactory. Here, we first report a biomimetic nanoplatform based on red blood cell membrane–coated cerium metal–organic frameworks (Ce-MOF-RBC) that enables multi-target synergistic intervention against AD. The Ce-MOF core exhibits potent antioxidant activity, efficiently scavenging reactive oxygen species (ROS) and restoring mitochondrial membrane potential, while its carboxylate ligands chelate Cu2 + with high efficiency (49.26 %) to inhibit Cu2+-induced Aβ fibrillation and disassemble preformed fibrils. Ce-MOF-RBC further modulates microglial phenotype, enhancing Aβ phagocytosis and reducing neuroinflammation. Importantly, RBC membrane functionalization markedly improves biological performance by prolonging systemic circulation, enhancing blood–brain barrier (BBB) penetration, and leveraging its intrinsic affinity for Aβ peptides to enrich Aβ. In vivo fluorescence imaging and brain cryosections showed that Ce-MOF-RBC achieved robust accumulation in the cortex and hippocampus, with brain fluorescence intensities 27.33-fold higher than free DiD. In the C. elegans AD model, Ce-MOF-RBC reduced Aβ plaque fluorescence by 32.54 %, lowered ROS levels by 45.72 %, improved chemotaxis performance (chemotaxis index increased from 34.24 % to 68.34 %), and delayed paralysis onset from 10 h to 15 h, demonstrating significant rescue of cognitive and motor deficits. In summary, these findings highlight the first demonstration of a small-sized, biomimetic Ce-MOF-RBC nanoplatform that integrates antioxidant, metal-chelating, anti-aggregation, and immunomodulatory functions, offering a promising strategy for comprehensive AD therapy.
{"title":"Biomimetic red blood cell membrane–coated cerium metal–organic framework for multi-target synergistic therapy of Alzheimer’s disease","authors":"Fengmei Yang , Yutong Chen , Yujiao Yan , Ruixin Zhao , Liran Deng , Die Tian , Meng Xie","doi":"10.1016/j.colsurfb.2026.115464","DOIUrl":"10.1016/j.colsurfb.2026.115464","url":null,"abstract":"<div><div>Pathological events in Alzheimer’s disease (AD) typically involve β-amyloid (Aβ) plaque deposition, metal ion dysregulation, oxidative stress elevation, and chronic neuroinflammation, making single-target therapies unsatisfactory. Here, we first report a biomimetic nanoplatform based on red blood cell membrane–coated cerium metal–organic frameworks (Ce-MOF-RBC) that enables multi-target synergistic intervention against AD. The Ce-MOF core exhibits potent antioxidant activity, efficiently scavenging reactive oxygen species (ROS) and restoring mitochondrial membrane potential, while its carboxylate ligands chelate Cu<sup>2 +</sup> with high efficiency (49.26 %) to inhibit Cu<sup>2+</sup>-induced Aβ fibrillation and disassemble preformed fibrils. Ce-MOF-RBC further modulates microglial phenotype, enhancing Aβ phagocytosis and reducing neuroinflammation. Importantly, RBC membrane functionalization markedly improves biological performance by prolonging systemic circulation, enhancing blood–brain barrier (BBB) penetration, and leveraging its intrinsic affinity for Aβ peptides to enrich Aβ. In vivo fluorescence imaging and brain cryosections showed that Ce-MOF-RBC achieved robust accumulation in the cortex and hippocampus, with brain fluorescence intensities 27.33-fold higher than free DiD. In the <em>C. elegans</em> AD model, Ce-MOF-RBC reduced Aβ plaque fluorescence by 32.54 %, lowered ROS levels by 45.72 %, improved chemotaxis performance (chemotaxis index increased from 34.24 % to 68.34 %), and delayed paralysis onset from 10 h to 15 h, demonstrating significant rescue of cognitive and motor deficits. In summary, these findings highlight the first demonstration of a small-sized, biomimetic Ce-MOF-RBC nanoplatform that integrates antioxidant, metal-chelating, anti-aggregation, and immunomodulatory functions, offering a promising strategy for comprehensive AD therapy.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"262 ","pages":"Article 115464"},"PeriodicalIF":5.6,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146048912","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-23DOI: 10.1016/j.colsurfb.2026.115469
Xiao Fu, Ting Lei, Linxin Liu, Yanfeng Liu
Dialysis membrane-related hemolysis (DMH) is an important factor influencing blood purification efficacy in critically ill patients. However, the pre-hemolysis fatigue process of RBCs and whether RBC fatigue can induce thrombus formation remains largely unexplored. In this study, rhein-modified polysulfone (PSf) hemodialysis membranes (RH membranes) were fabricated, and their impact on RBC fatigue and thrombus formation was investigated. In this study, the RH membranes demonstrated potent physicochemical properties and hemodialysis performance, effectively inhibiting RBC fatigue and RMPs formation, and alleviating hemoglobin (Hb)-mediated sublethal damage. Furthermore, we showed that RH membranes exhibited antithrombotic efficacy by diminishing RMPs formation and subsequently inhibiting activation of predominant coagulation pathways and key coagulation factors. In the murine model of acute hemolysis, the RH membranes mitigated DMH in vivo and provided anticoagulation and organ-protective effects. In conclusion, RH membranes are a promising option for hemodialysis treatment in critically ill patients.
{"title":"Rhein-modified hemodialysis membranes suppress red blood cell fatigue and thrombosis.","authors":"Xiao Fu, Ting Lei, Linxin Liu, Yanfeng Liu","doi":"10.1016/j.colsurfb.2026.115469","DOIUrl":"https://doi.org/10.1016/j.colsurfb.2026.115469","url":null,"abstract":"<p><p>Dialysis membrane-related hemolysis (DMH) is an important factor influencing blood purification efficacy in critically ill patients. However, the pre-hemolysis fatigue process of RBCs and whether RBC fatigue can induce thrombus formation remains largely unexplored. In this study, rhein-modified polysulfone (PSf) hemodialysis membranes (RH membranes) were fabricated, and their impact on RBC fatigue and thrombus formation was investigated. In this study, the RH membranes demonstrated potent physicochemical properties and hemodialysis performance, effectively inhibiting RBC fatigue and RMPs formation, and alleviating hemoglobin (Hb)-mediated sublethal damage. Furthermore, we showed that RH membranes exhibited antithrombotic efficacy by diminishing RMPs formation and subsequently inhibiting activation of predominant coagulation pathways and key coagulation factors. In the murine model of acute hemolysis, the RH membranes mitigated DMH in vivo and provided anticoagulation and organ-protective effects. In conclusion, RH membranes are a promising option for hemodialysis treatment in critically ill patients.</p>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"262 ","pages":"115469"},"PeriodicalIF":5.6,"publicationDate":"2026-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146155534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-22DOI: 10.1016/j.colsurfb.2026.115453
Elif Naz Gürsoy, M. Burcu Kulahci, Kubra Sener, K. Barbaros Balabanli, Sule Coskun Cevher
Bacterial cellulose (BC) is a nanostructured biopolymer renowned for its high crystallinity, exceptional water-holding capacity, and biocompatibility. While interspecies differences in BC properties are documented, comprehensive insights into strain-level biosynthetic variability within and across Komagataeibacter species remain limited. In this study, ten BC-producing strains were isolated from vinegar samples of diverse botanical origins and identified via 16S rRNA sequencing as belonging to three species: K. europaeus, K. medellinensis, and K. xylinus. Despite the limited taxonomic diversity, the isolates exhibited ten distinct “biosynthetic fingerprints,” as evidenced by pronounced variations in production yield, micro- and nanostructural morphology (FE-SEM), chemical functionality (FTIR), crystallinity (XRD), thermal stability (TGA), and water-holding capacity (WHC). Quantitatively, BC yields ranged from 2.10 to 3.01 g L⁻¹ , crystallinity indices from 34.5 % to 65.6 %, DTG_max from 337.4 °C to 372.1 °C, and WHC from 87.3 % to 95.7 %. Interestingly, some low-crystallinity samples demonstrated higher thermal stability, indicating that microstructural organization and fibril network compactness contribute significantly to thermal resistance beyond crystallinity alone. These findings establish that vinegar-derived Komagataeibacter strains harbor substantial strain-specific structural and functional heterogeneity, underscoring the necessity of strain-level selection and characterization when tailoring BC for advanced biomedical and industrial applications.
{"title":"Biosynthetic fingerprints and strain-specific characterization of bacterial cellulose from vinegar-derived Komagataeibacter spp.","authors":"Elif Naz Gürsoy, M. Burcu Kulahci, Kubra Sener, K. Barbaros Balabanli, Sule Coskun Cevher","doi":"10.1016/j.colsurfb.2026.115453","DOIUrl":"10.1016/j.colsurfb.2026.115453","url":null,"abstract":"<div><div>Bacterial cellulose (BC) is a nanostructured biopolymer renowned for its high crystallinity, exceptional water-holding capacity, and biocompatibility. While interspecies differences in BC properties are documented, comprehensive insights into strain-level biosynthetic variability within and across Komagataeibacter species remain limited. In this study, ten BC-producing strains were isolated from vinegar samples of diverse botanical origins and identified via 16S rRNA sequencing as belonging to three species: K. europaeus, K. medellinensis, and K. xylinus. Despite the limited taxonomic diversity, the isolates exhibited ten distinct “biosynthetic fingerprints,” as evidenced by pronounced variations in production yield, micro- and nanostructural morphology (FE-SEM), chemical functionality (FTIR), crystallinity (XRD), thermal stability (TGA), and water-holding capacity (WHC). Quantitatively, BC yields ranged from 2.10 to 3.01 g L⁻¹ , crystallinity indices from 34.5 % to 65.6 %, DTG_max from 337.4 °C to 372.1 °C, and WHC from 87.3 % to 95.7 %. Interestingly, some low-crystallinity samples demonstrated higher thermal stability, indicating that microstructural organization and fibril network compactness contribute significantly to thermal resistance beyond crystallinity alone. These findings establish that vinegar-derived Komagataeibacter strains harbor substantial strain-specific structural and functional heterogeneity, underscoring the necessity of strain-level selection and characterization when tailoring BC for advanced biomedical and industrial applications.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"262 ","pages":"Article 115453"},"PeriodicalIF":5.6,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146076988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cranial defect repair is frequently hindered by limited intrinsic regenerative capacity, infection risks, and chronic inflammation, whereas conventional grafts and inert implants often suffer from poor host integration. Herein, we report an extracellular matrix–mimicking hydrogel that synchronizes angiogenesis, osteogenesis, and immunomodulation through dynamic thiol–disulfide chemistry and sacrificial prevascularization. Hyaluronic acid functionalized with L-cysteine ethyl ester (HACys) was crosslinked with allicin to yield a viscoadaptive, stress-relaxing network, within which type I collagen was extruded into VEGF-loaded threads to serve as sacrificial templates (HACys-VEGF@Coll-A). Upon enzymatic degradation, these threads generated VEGF-lined microchannels designed to guide rapid vascular ingress. The composite demonstrated excellent cytocompatibility with BMSCs and selectively enhanced HUVEC viability and spreading. Furthermore, VEGF-presenting constructs significantly promoted endothelial tube formation and migration while upregulating VEGF mRNA, confirming preserved bioactivity. In BMSCs, VEGF-containing hydrogels increased alkaline phosphatase activity and mineral deposition, concomitant with the upregulation of osteogenic genes (ALP, COL1, RUNX2, OCN). Notably, macrophages shifted from a CD86high/CD206low toward a CD86low/CD206high phenotype with decreased TNF-α and increased IL-10 secretion, indicating the establishment of a pro-resolution immune microenvironment. Collectively, HACys-VEGF@Coll-A forms a dynamic, remodelable scaffold that integrates preformed vascular conduits while supporting osteogenesis and tempering inflammation, thereby addressing major barriers to cranial defect repair and warranting further in vivo evaluation of release kinetics, channel architecture, and mechanics.
{"title":"Dynamic linking bone ECM-mimic hydrogel for anti-inflammatory therapy of cranial defect","authors":"Tao Ge, Hongcai Wang, Mengmeng Qiu, Kuan Feng, Taotao Shi, Jia Li, Shidi Yang, Maosong Chen","doi":"10.1016/j.colsurfb.2026.115462","DOIUrl":"10.1016/j.colsurfb.2026.115462","url":null,"abstract":"<div><div>Cranial defect repair is frequently hindered by limited intrinsic regenerative capacity, infection risks, and chronic inflammation, whereas conventional grafts and inert implants often suffer from poor host integration. Herein, we report an extracellular matrix–mimicking hydrogel that synchronizes angiogenesis, osteogenesis, and immunomodulation through dynamic thiol–disulfide chemistry and sacrificial prevascularization. Hyaluronic acid functionalized with <span>L</span>-cysteine ethyl ester (HACys) was crosslinked with allicin to yield a viscoadaptive, stress-relaxing network, within which type I collagen was extruded into VEGF-loaded threads to serve as sacrificial templates (HACys-VEGF@Coll-A). Upon enzymatic degradation, these threads generated VEGF-lined microchannels designed to guide rapid vascular ingress. The composite demonstrated excellent cytocompatibility with BMSCs and selectively enhanced HUVEC viability and spreading. Furthermore, VEGF-presenting constructs significantly promoted endothelial tube formation and migration while upregulating VEGF mRNA, confirming preserved bioactivity. In BMSCs, VEGF-containing hydrogels increased alkaline phosphatase activity and mineral deposition, concomitant with the upregulation of osteogenic genes (ALP, COL1, RUNX2, OCN). Notably, macrophages shifted from a CD86high/CD206low toward a CD86low/CD206high phenotype with decreased TNF-α and increased IL-10 secretion, indicating the establishment of a pro-resolution immune microenvironment. Collectively, HACys-VEGF@Coll-A forms a dynamic, remodelable scaffold that integrates preformed vascular conduits while supporting osteogenesis and tempering inflammation, thereby addressing major barriers to cranial defect repair and warranting further in vivo evaluation of release kinetics, channel architecture, and mechanics.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"262 ","pages":"Article 115462"},"PeriodicalIF":5.6,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146076996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-22DOI: 10.1016/j.colsurfb.2026.115468
Jiao Zhang , Hao Sun , Hui Yuan , Wenyu Chen , Jialin Yan , Jie Ren , Ting Hu , Yuhang Li
Psoriasis is a chronic inflammatory disorder with a worldwide prevalence of 1–3 %, which has no cure. By inducing inflammation, keratinocyte hyperproliferation, and oxidative stress, reactive oxygen species (ROS) play a pivotal role in the pathogenesis of psoriasis. Although the clinical application of ROS-scavenging nanozymes is expected, their translation has been limited by complicated synthesis and high cost. To bypass these problems, in the present study, cerium cobalt composite nanoparticles (CC NPs) were fabricated via facile coprecipitation. The optimization results revealed that 8CC NPs (CeCo = 8:2) were optimal with uniform spherical morphology and enhanced oxygen vacancies, which enhanced the ROS-scavenging activities, and enabled the efficient scavenging of H2O2, O2•-, and •OH radicals. Then, 8CC NPs suppressed the intracellular ROS accumulation, inhibited proliferation, and attenuated the NF-κB inflammatory signaling in the IL-17-stimulated HaCaT keratinocytes. Additionally, in a murine imiquimod-induced psoriasis model, the treatment with 8CC NPs markedly alleviated the clinical symptoms, and no toxicity was observed. Therefore, CC NPs could serve as a novel, cost-effective, and biocompatible nanozyme platform with powerful ROS scavenging, simple synthesis, and promising inflammatory suppression, which provided strong support for their application in the translation of psoriasis. Given the inherent differences between murine models and human psoriasis, further studies are essential to validate the therapeutic potential of this nanozyme platform in clinical settings.
{"title":"Cerium-cobalt composite nanoparticles (CC NPs) as a multifunctional reactive oxygen species (ROS) scavenger for psoriasis therapy","authors":"Jiao Zhang , Hao Sun , Hui Yuan , Wenyu Chen , Jialin Yan , Jie Ren , Ting Hu , Yuhang Li","doi":"10.1016/j.colsurfb.2026.115468","DOIUrl":"10.1016/j.colsurfb.2026.115468","url":null,"abstract":"<div><div>Psoriasis is a chronic inflammatory disorder with a worldwide prevalence of 1–3 %, which has no cure. By inducing inflammation, keratinocyte hyperproliferation, and oxidative stress, reactive oxygen species (ROS) play a pivotal role in the pathogenesis of psoriasis. Although the clinical application of ROS-scavenging nanozymes is expected, their translation has been limited by complicated synthesis and high cost. To bypass these problems, in the present study, cerium cobalt composite nanoparticles (CC NPs) were fabricated via facile coprecipitation. The optimization results revealed that 8CC NPs (CeCo = 8:2) were optimal with uniform spherical morphology and enhanced oxygen vacancies, which enhanced the ROS-scavenging activities, and enabled the efficient scavenging of H<sub>2</sub>O<sub>2</sub>, O<sub>2</sub>•<sup>-</sup>, and •OH radicals. Then, 8CC NPs suppressed the intracellular ROS accumulation, inhibited proliferation, and attenuated the NF-κB inflammatory signaling in the IL-17-stimulated HaCaT keratinocytes. Additionally, in a murine imiquimod-induced psoriasis model, the treatment with 8CC NPs markedly alleviated the clinical symptoms, and no toxicity was observed. Therefore, CC NPs could serve as a novel, cost-effective, and biocompatible nanozyme platform with powerful ROS scavenging, simple synthesis, and promising inflammatory suppression, which provided strong support for their application in the translation of psoriasis. Given the inherent differences between murine models and human psoriasis, further studies are essential to validate the therapeutic potential of this nanozyme platform in clinical settings.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"262 ","pages":"Article 115468"},"PeriodicalIF":5.6,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146048909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nanozymes are engineered nanomaterials designed at the atomic scale to fine-tune their structure, composition, and electronic properties, thereby creating active sites that mimic those of natural enzymes. Among these materials, Metal-organic frameworks (MOFs) are notable for their well-defined, porous frameworks, which are created by connecting metal ions or clusters with organic linkers. Their large surface area, adjustable porosity, and superior biocompatibility enable excellent catalytic activity. By containing specific catalytic functionalities, MOF-based nanozymes can mimic peroxidase, oxidase, catalase, and superoxide dismutase activities. These properties make them genuinely promising for biomedical applications, particularly in cancer diagnosis and therapy. Recent progress in synthetic design, post-synthetic modification, and machine learning–assisted optimization has enhanced their structural precision and catalytic efficiency. Furthermore, MOFs serve as multifunctional therapeutic platforms capable of supporting combined treatment strategies and producing synergistic therapeutic effects, thereby establishing their potential as next-generation systems for targeted cancer treatment and diagnostic integration.
{"title":"Recent advances in metal-organic framework-based nanozymes for cancer theranostics driven by synthetic innovation and machine learning design","authors":"Sangeeta Yadav , Aditi Sarkar , Saurabh Shivalkar , Fiza Fatima , Siddharth Kumar Thakur , Ankita Chaudhary , Sintu Kumar Samanta , Amaresh Kumar Sahoo","doi":"10.1016/j.colsurfb.2026.115463","DOIUrl":"10.1016/j.colsurfb.2026.115463","url":null,"abstract":"<div><div>Nanozymes are engineered nanomaterials designed at the atomic scale to fine-tune their structure, composition, and electronic properties, thereby creating active sites that mimic those of natural enzymes. Among these materials, Metal-organic frameworks (MOFs) are notable for their well-defined, porous frameworks, which are created by connecting metal ions or clusters with organic linkers. Their large surface area, adjustable porosity, and superior biocompatibility enable excellent catalytic activity. By containing specific catalytic functionalities, MOF-based nanozymes can mimic peroxidase, oxidase, catalase, and superoxide dismutase activities. These properties make them genuinely promising for biomedical applications, particularly in cancer diagnosis and therapy. Recent progress in synthetic design, post-synthetic modification, and machine learning–assisted optimization has enhanced their structural precision and catalytic efficiency. Furthermore, MOFs serve as multifunctional therapeutic platforms capable of supporting combined treatment strategies and producing synergistic therapeutic effects, thereby establishing their potential as next-generation systems for targeted cancer treatment and diagnostic integration.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"261 ","pages":"Article 115463"},"PeriodicalIF":5.6,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146074301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-20DOI: 10.1016/j.colsurfb.2026.115466
Qiqi Li , Yaochen Deng , Xiaolu Han , Yuhan Dong , Xianggen Wu , Wei Zhu , Meixing Yan
Naringenin (NAR) possesses remarkable hepatoprotective potential. However, its extremely low aqueous solubility and oral bioavailability greatly constrain its therapeutic efficacy. To overcome these limitations, we developed a novel oral nanodelivery system, NanoNAR@Glycygel, by embedding NAR nanosuspensions (NanoNAR) into a self-assembled glycyrrhizin-based hydrogel (Glycygel). The design of this delivery system improves solubility, enhances absorption, and provides synergistic hepatoprotective effects. NanoNAR, when stabilized by the natural biosurfactant glycyrrhizin, exhibited a uniform particle size of approximately 230 nm and showed markedly improved solubility in physiologically relevant media. The hydrogel network formed by Glycygel effectively encapsulated NanoNAR, further enhancing its solubility and controlled release behavior. Pharmacokinetic analyses revealed that NanoNAR@Glycygel significantly enhanced the oral bioavailability of NAR and increased its hepatic accumulation, demonstrating how the synergistic interplay between nanonization and the glycyrrhizin hydrogel matrix facilitates rapid absorption and sustained release. In a cholestatic liver injury mouse model, NanoNAR@Glycygel treatment markedly alleviated cholestasis and hepatic histopathological damage, restoring liver morphology and serum biochemical parameters to near-normal levels. Mechanistic investigations revealed for the first time that HMGB1 signaling is involved in this cholestatic liver injury, and NanoNAR@Glycygel exerted its potent therapeutic effect by inhibiting this signaling. The NanoNAR@Glycygel cloud also reduced malondialdehyde (MDA) levels and enhanced superoxide (SOD) activity, thereby mitigating oxidative injury. Collectively, these findings demonstrate that NanoNAR@Glycygel is a safe, simple, and highly effective oral delivery platform that not only unleashes the therapeutic potential of NAR but also highlights the distinctive advantages of glycyrrhizin-based matrices for the targeted oral delivery of hydrophobic natural bioactives.
{"title":"Naringenin nanosuspensions embedded glycyrrhizin-based hydrogel ameliorates cholestatic liver injury in mice by inhibiting oxidative stress and HMGB1-mediated inflammation","authors":"Qiqi Li , Yaochen Deng , Xiaolu Han , Yuhan Dong , Xianggen Wu , Wei Zhu , Meixing Yan","doi":"10.1016/j.colsurfb.2026.115466","DOIUrl":"10.1016/j.colsurfb.2026.115466","url":null,"abstract":"<div><div>Naringenin (NAR) possesses remarkable hepatoprotective potential. However, its extremely low aqueous solubility and oral bioavailability greatly constrain its therapeutic efficacy. To overcome these limitations, we developed a novel oral nanodelivery system, NanoNAR@Glycygel, by embedding NAR nanosuspensions (NanoNAR) into a self-assembled glycyrrhizin-based hydrogel (Glycygel). The design of this delivery system improves solubility, enhances absorption, and provides synergistic hepatoprotective effects. NanoNAR, when stabilized by the natural biosurfactant glycyrrhizin, exhibited a uniform particle size of approximately 230 nm and showed markedly improved solubility in physiologically relevant media. The hydrogel network formed by Glycygel effectively encapsulated NanoNAR, further enhancing its solubility and controlled release behavior. Pharmacokinetic analyses revealed that NanoNAR@Glycygel significantly enhanced the oral bioavailability of NAR and increased its hepatic accumulation, demonstrating how the synergistic interplay between nanonization and the glycyrrhizin hydrogel matrix facilitates rapid absorption and sustained release. In a cholestatic liver injury mouse model, NanoNAR@Glycygel treatment markedly alleviated cholestasis and hepatic histopathological damage, restoring liver morphology and serum biochemical parameters to near-normal levels. Mechanistic investigations revealed for the first time that HMGB1 signaling is involved in this cholestatic liver injury, and NanoNAR@Glycygel exerted its potent therapeutic effect by inhibiting this signaling. The NanoNAR@Glycygel cloud also reduced malondialdehyde (MDA) levels and enhanced superoxide (SOD) activity, thereby mitigating oxidative injury. Collectively, these findings demonstrate that NanoNAR@Glycygel is a safe, simple, and highly effective oral delivery platform that not only unleashes the therapeutic potential of NAR but also highlights the distinctive advantages of glycyrrhizin-based matrices for the targeted oral delivery of hydrophobic natural bioactives.</div></div>","PeriodicalId":279,"journal":{"name":"Colloids and Surfaces B: Biointerfaces","volume":"261 ","pages":"Article 115466"},"PeriodicalIF":5.6,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146035620","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}